Home/Filings/4/0001209191-21-065616
4//SEC Filing

Morosini Deborah 4

Accession 0001209191-21-065616

CIK 0001678660other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 6:42 PM ET

Size

11.5 KB

Accession

0001209191-21-065616

Insider Transaction Report

Form 4
Period: 2021-11-16
Morosini Deborah
EVP, Chief of Clinical Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2021-11-16$12.85/sh+28,751$369,45029,195 total
  • Sale

    Common Stock

    2021-11-16$15.87/sh28,351$449,962844 total
  • Sale

    Common Stock

    2021-11-16$16.43/sh400$6,570444 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-11-1628,751196,045 total
    Exercise: $12.85Exp: 2030-09-01Common Stock (28,751 underlying)
Footnotes (4)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.41 to $16.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  • [F4]The stock option vested as to 25% of the total shares monthly beginning on July 27, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001824625

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 6:42 PM ET
Size
11.5 KB